hTERT mRNA partially regulates telomerase activity in gastric adenocarcinoma and adjacent normal gastric mucosa

被引:18
作者
Barclay, JY
Morris, AG
Nwokolo, CU
机构
[1] Univ Hosp Coventry & Warwickshire, Coventry CV2 2DX, W Midlands, England
[2] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England
关键词
telomerase; hTERT mRNA; gastric adenocarcinoma;
D O I
10.1007/s10620-005-2776-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The extent to which human telomerase reverse transcriptase (hTERT) mRNA and its splice variants control telomerase activity in human cancers is controversial. Telomerase and hTERT mRNA were assessed quantitatively in paired samples of gastric adenocarcinoma and adjacent normal tissue. Splice variants within the hTERT reverse transcriptase domain (alpha beta, alpha beta) were detected by RT-PCR. In gastric adenocarcinoma, compared to normal tissue, median telomerase activity increased significantly (from 0 total product generated [tpg; 95% confidence interval CI, 0-2.3] to 16.1 tpg [95% CI, 3.7-97]; P = 0.008) and median hTERT mRNA levels also increased (from 2.21 [95% CI, 1.40-4.62] to 7.08 [95% CI, 3.26-10.8]; P = 0.0054). hTERT mRNA and telomerase activity correlated in normal gastric mucosa (r = 0.819, P = 0.0002). alpha, beta and alpha beta deletions were similar in both groups. We conclude that hTERT mRNA partially regulates telomerase activity in normal gastric mucosa and gastric adenocarcinoma. In contrast, hTERT mRNA splicing is not involved in the regulation of enzyme activity.
引用
收藏
页码:1299 / 1303
页数:5
相关论文
共 27 条
[1]
Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[2]
Alternative splicing of the telomerase catalytic subunit in human oocytes and embryos [J].
Brenner, CA ;
Wolny, YM ;
Adler, RR ;
Cohen, J .
MOLECULAR HUMAN REPRODUCTION, 1999, 5 (09) :845-850
[3]
The hTERTα splice variant is a dominant negative inhibitor of telomerase activity [J].
Colgin, LM ;
Wilkinson, C ;
Englezou, A ;
Kilian, A ;
Robinson, MO ;
Reddel, RR .
NEOPLASIA, 2000, 2 (05) :426-432
[4]
Jong HS, 1999, CANCER, V86, P559, DOI 10.1002/(SICI)1097-0142(19990815)86:4<559::AID-CNCR3>3.0.CO
[5]
2-4
[6]
Kanaya T, 2000, CLIN CANCER RES, V6, P1239
[7]
Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase [J].
Kharbanda, S ;
Kumar, V ;
Dhar, S ;
Pandey, P ;
Chen, C ;
Majumder, P ;
Yuan, ZM ;
Whang, Y ;
Strauss, W ;
Pandita, TK ;
Weaver, D ;
Kufe, D .
CURRENT BIOLOGY, 2000, 10 (10) :568-575
[8]
Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP) [J].
Kim, NW ;
Wu, F .
NUCLEIC ACIDS RESEARCH, 1997, 25 (13) :2595-2597
[9]
Kyo S, 1999, CANCER RES, V59, P5917
[10]
Telomerase is controlled by protein kinase Cα in human breast cancer cells [J].
Li, H ;
Zhao, LL ;
Yang, ZY ;
Funder, JW ;
Liu, JP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (50) :33436-33442